ECTRIMS 2024 | Improving the global applicability of the new MS diagnostic criteria

Marcello Moccia, MD, PhD, University of Naples Federico II, Naples, Italy, discusses the process used to develop the novel diagnostic criteria for multiple sclerosis (MS). To improve the applicability and relevance of the criteria globally, evidence from specialist centers worldwide was collated to reach a consensus on the most appropriate criteria for diagnosing the disease. This interview took place at the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2024) in Copenhagen, Denmark.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.